A closer look at 'friend-shoring' and the drug shortage challenge

In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.

"Friend-shoring" involves conducting manufacturing processes in countries considered friendly or allied. Sheng discusses the criteria for deeming a country “friendly” and explores whether this strategy could help address drug supply shortages.

To learn more about the topics in this episode:

• Bora plants its flag in the US with $210M acquisition of generics manufacturer Upsher-Smith
• Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M

See omnystudio.com/listener for privacy information.